Grant: Operating Grant: Sparks Grant - General Pool
University of Calgary
$75,000.00
Using novel bio-dosimetry to measure personalized, lifetime radon gas exposure and transform the prevention and early detection of lung cancer
EF 2020-21
Résumé
1 in 5 Canadian lung cancers occur in never-smokers, who typically struggle to pinpoint their disease’s origins at the individual level. At a population level, widespread radioactive radon gas inhalation is the 2nd leading cause of lung cancer in Canada. However, essentially no-one has reliable, individualized data measuring personal radon exposure going back to birth, limiting never-smoker and/or radon-induced lung cancer prevention and early cancer detection.This is unacceptable but solvable. There is an unmet need for new technology useful to determine lifetime radon exposure at an individual level. We will meet this challenge by bringing together population health, radiation biology and atomic physics to develop practical ways of measuring personalized lifetime radon exposure retroactively, from easily accessible, disposable tissues, and in a manner that will inform health decision making to transform radon-induced lung cancer prevention and early detection in Canada. We will use isotope dilution mass spectrometry to determine if internal, solid radon-decay product accumulation can be measured using human toenails in a sufficiently sensitive manner to inform lifetime radon exposure. To achieve this, we have assembled the atomic physics tools and skills needed measure radon-decay products in tissue, coupled with the capacity to obtain and analyze toenail samples from people with reliable long-term radon dosimetry data. Success will mean a reliable, new technology application that permits: (1) those gaining knowledge of hitherto unknown radon exposure to take informed preventative action earlier and/or at a lower radon threshold, (2) screening program referral to become cost effective for radon-exposed never- and light-smokers and, (3) lung cancer diagnosis as early as possible based on verified exposure history (this is so important for never smokers). This will transform the currently inadequate status quo of radon-induced lung cancer prevention and early detection, specifically enhancing the inclusivity and effectiveness of lung cancer screening.
Programme
Operating Grant: Sparks Grant - General Pool
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
442519
Name
Goodarzi Aaron
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Cancer Society - National Office (Toronto); Canadian Cancer Society - National Office (Toronto); Brain Canada Foundation (Montreal, Québec)
Prcname2
Special Cases
Projecttitle
Using novel bio-dosimetry to measure personalized, lifetime radon gas exposure and transform the prevention and early detection of lung cancer
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Operating Grant: Sparks Grant - General Pool
Keyworddelim
Early Detection; Environment; Lung; Mass Spectrometry; Never-Smoker Lung; Prevention; Radon Gas
Abstract
1 in 5 Canadian lung cancers occur in never-smokers, who typically struggle to pinpoint their disease’s origins at the individual level. At a population level, widespread radioactive radon gas inhalation is the 2nd leading cause of lung cancer in Canada. However, essentially no-one has reliable, individualized data measuring personal radon exposure going back to birth, limiting never-smoker and/or radon-induced lung cancer prevention and early cancer detection.This is unacceptable but solvable. There is an unmet need for new technology useful to determine lifetime radon exposure at an individual level. We will meet this challenge by bringing together population health, radiation biology and atomic physics to develop practical ways of measuring personalized lifetime radon exposure retroactively, from easily accessible, disposable tissues, and in a manner that will inform health decision making to transform radon-induced lung cancer prevention and early detection in Canada. We will use isotope dilution mass spectrometry to determine if internal, solid radon-decay product accumulation can be measured using human toenails in a sufficiently sensitive manner to inform lifetime radon exposure. To achieve this, we have assembled the atomic physics tools and skills needed measure radon-decay products in tissue, coupled with the capacity to obtain and analyze toenail samples from people with reliable long-term radon dosimetry data. Success will mean a reliable, new technology application that permits: (1) those gaining knowledge of hitherto unknown radon exposure to take informed preventative action earlier and/or at a lower radon threshold, (2) screening program referral to become cost effective for radon-exposed never- and light-smokers and, (3) lung cancer diagnosis as early as possible based on verified exposure history (this is so important for never smokers). This will transform the currently inadequate status quo of radon-induced lung cancer prevention and early detection, specifically enhancing the inclusivity and effectiveness of lung cancer screening.
Competitiondate
202010
Approvedterm2
1 yr 0 mth
Pinamesdelim
Goodarzi, Aaron
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $75,000~ $0~